sacituzumab govitecan
gilead sciences
['tropics-02', 'breast', 'sacituzumab']
sacituzumab govitecan has shown promising pfs results for hr+/her2- metastatic breast cancer in the tropics-02 trial. #asco22
Oncology Central is the online resource for #oncology professionals, powered by Future Science Group. Senior Editors @JadeParkerB @racheljenkinsOC